Panagora Asset Management Inc Vertex Pharmaceuticals Inc Transaction History

Panagora Asset Management Inc

$19.7 Billion
Q2 2024

A detailed history of Panagora Asset Management Inc transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Panagora Asset Management Inc holds 48,554 shares of VRTX stock, worth $23 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares

48,554

Previous 100,170 51.53%

Holding current value

$23 Million

Previous $41.9 Million 45.65%

% of portfolio

0.12%

Previous 0.22%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 29, 2024	SELL	$392.81 - $485.53 $20.3 Million - $25.1 Million	-51,616 Reduced 51.53%	48,554 $22.8 Million
Q1 2024 May 07, 2024	SELL	$407.69 - $446.08 $54.6 Million - $59.8 Million	-133,961 Reduced 57.22%	100,170 $41.9 Million
Q4 2023 Feb 08, 2024	BUY	$343.0 - $410.68 $11.2 Million - $13.4 Million	32,612 Added 16.18%	234,131 $95.3 Million
Q3 2023 Oct 31, 2023	BUY	$338.18 - $362.46 $35.7 Million - $38.3 Million	105,608 Added 110.11%	201,519 $70.1 Million
Q2 2023 Aug 11, 2023	BUY	$314.42 - $351.91 $19 Million - $21.3 Million	60,495 Added 170.81%	95,911 $33.8 Million
Q1 2023 May 11, 2023	SELL	$283.23 - $323.1 $21.4 Million - $24.4 Million	-75,526 Reduced 68.08%	35,416 $11.2 Million
Q4 2022 Feb 13, 2023	BUY	$285.76 - $321.48 $9.97 Million - $11.2 Million	34,885 Added 45.87%	110,942 $32 Million
Q3 2022 Nov 14, 2022	SELL	$273.83 - $305.53 $6,024 - $6,721	-22 Reduced 0.03%	76,057 $22 Million
Q2 2022 Aug 15, 2022	SELL	$234.96 - $292.55 $25.6 Million - $31.9 Million	-108,918 Reduced 58.88%	76,079 $21.4 Million
Q1 2022 May 12, 2022	SELL	$221.42 - $260.97 $19.8 Million - $23.3 Million	-89,263 Reduced 32.55%	184,997 $48.3 Million
Q4 2021 Feb 10, 2022	SELL	$177.01 - $223.45 $20.5 Million - $25.8 Million	-115,628 Reduced 29.66%	274,260 $60.2 Million
Q3 2021 Nov 10, 2021	BUY	$181.39 - $202.99 $16.5 Million - $18.5 Million	90,980 Added 30.44%	389,888 $70.7 Million
Q2 2021 Aug 11, 2021	BUY	$187.49 - $221.1 $13.4 Million - $15.8 Million	71,477 Added 31.43%	298,908 $60.3 Million
Q1 2021 May 12, 2021	BUY	$207.02 - $241.31 $38.4 Million - $44.7 Million	185,337 Added 440.29%	227,431 $48.9 Million
Q4 2020 Feb 10, 2021	SELL	$207.01 - $276.09 $10.3 Million - $13.8 Million	-49,947 Reduced 54.27%	42,094 $9.95 Million
Q3 2020 Nov 13, 2020	BUY	$255.65 - $303.1 $3.67 Million - $4.35 Million	14,368 Added 18.5%	92,041 $25 Million
Q2 2020 Aug 12, 2020	BUY	$225.48 - $295.8 $21,871 - $28,692	97 Added 0.13%	77,673 $22.5 Million
Q1 2020 May 14, 2020	SELL	$199.77 - $247.81 $110,472 - $137,038	-553 Reduced 0.71%	77,576 $18.5 Million
Q4 2019 Feb 12, 2020	SELL	$166.71 - $223.91 $30.5 Million - $40.9 Million	-182,691 Reduced 70.04%	78,129 $17.1 Million
Q3 2019 Nov 12, 2019	SELL	$166.23 - $187.09 $79.6 Million - $89.6 Million	-478,708 Reduced 64.73%	260,820 $44.2 Million
Q2 2019 Aug 09, 2019	SELL	$164.61 - $190.37 $19.2 Million - $22.2 Million	-116,764 Reduced 13.64%	739,528 $136 Million
Q1 2019 May 15, 2019	SELL	$163.73 - $194.7 $78.5 Million - $93.4 Million	-479,597 Reduced 35.9%	856,292 $158 Million
Q4 2018 Feb 14, 2019	SELL	$151.91 - $192.21 $18 Million - $22.8 Million	-118,675 Reduced 8.16%	1,335,889 $221 Million
Q3 2018 Nov 13, 2018	BUY	$167.73 - $192.74 $83.7 Million - $96.2 Million	499,019 Added 52.22%	1,454,564 $280 Million
Q2 2018 Aug 14, 2018	BUY	$145.72 - $169.96 $10.7 Million - $12.5 Million	73,360 Added 8.32%	955,545 $162 Million
Q1 2018 May 15, 2018	BUY	$151.6 - $177.13 $9.33 Million - $10.9 Million	61,554 Added 7.5%	882,185 $144 Million
Q4 2017 Feb 14, 2018	BUY	$137.28 - $155.55 $8.55 Million - $9.69 Million	62,303 Added 8.22%	820,631 $123 Million
Q3 2017 Nov 14, 2017	BUY	$148.13 - $162.24 $112 Million - $123 Million	758,328	758,328 $115 Million

Others Institutions Holding VRTX

# of Institutions

1,707

Shares Held

226M

Call Options Held

1.2M

Put Options Held

1.59M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $122B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Panagora Asset Management Inc with notifications on news.

Account

Panagora Asset Management Inc Vertex Pharmaceuticals Inc Transaction History